Cafepharma Today

November 1 2024 - Novo, with new results, to seek approval for obesity drug in MASH
Novo, with new results, to seek approval for obesity drug in MASH
FDA reconsiders CAR-T boxed warning on secondary cancers
Drug pricing and the 2024 presidential election
Lexicon's type 1 diabetes drug voted down by FDA adcomm
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Isis Our Top Mid-Cap Biotech Pick
Yahoo/Zacks.com
Thursday, May 7, 2009 - 5:27pm
tags:
Isis Pharmaceuticals, biotech
Takeda to Start Sales and Marketing Operation in Portugal
Pharma Live
Thursday, May 7, 2009 - 10:51am
tags:
Takeda, Portugal, Europe
Is Amylin caving to proxy pressure?
Fierce Pharma
Thursday, May 7, 2009 - 10:29am
tags:
Amylin, diabetes
Shire Q1: The Big Fight Against Teva's Generics Begins
BNET Pharma
Thursday, May 7, 2009 - 10:27am
tags:
ADHD, Vyvanase, Adderall XR
Jazz Pharmaceuticals trims Q1 loss, misses payment
Bizjournals.com
Thursday, May 7, 2009 - 10:26am
tags:
Jazz Pharmaceuticals, earnings
Cheaper Generic Pills Saved US $734 Billion: Lobbyists
CNBC
Thursday, May 7, 2009 - 8:51am
tags:
generics, lobbying
Enzon Reports Strong 1st Quarter 2009 Results
Yahoo
Thursday, May 7, 2009 - 8:49am
tags:
Enzon, earnings
FDA Grants Priority Review Status to Prevnar 13 Marketing Application
Yahoo
Thursday, May 7, 2009 - 8:48am
tags:
FDA, Prevnar, Wyeth, vaccines
Sanofi-Aventis Bonds Trigger ‘Astonishing’ Demand, ING Says
Bloomberg
Thursday, May 7, 2009 - 6:28am
tags:
Sanofi, bonds
China drug maker Zensun eyes Nasdaq listing in 2011
Reuters, UK
Thursday, May 7, 2009 - 6:24am
tags:
China, Zensun, NASDAQ
Mixing Plavix, Heartburn Drugs Seen as Risky
WSJ Online
Thursday, May 7, 2009 - 6:21am
tags:
Plavix, heartburn, PPIs, Nexium
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
Yahoo
Thursday, May 7, 2009 - 6:20am
tags:
FDA, Vanda, schizophrenia, Fanapt
Access Pharma: Low Valuation, Big Potential
Seeking Alpha
Thursday, May 7, 2009 - 6:20am
tags:
Access Pharmaceuticals
Group wants boxed warning on constipation drug
Yahoo/AP
Thursday, May 7, 2009 - 6:18am
tags:
constipation, Sucampo, Pfizer, Amitiza
Novartis Puts Its Money Where Its Mouth is, Too
InVivo
Wednesday, May 6, 2009 - 6:13pm
tags:
Novartis, Actonel
Genzyme plans new Lumizyme application in weeks
Yahoo/AP
Wednesday, May 6, 2009 - 6:12pm
tags:
Genzyme, Lumizyme, Pompe disease
Charles River Labs hit by biotech downturn
Bizjournals.com
Wednesday, May 6, 2009 - 6:12pm
tags:
Charles River Laboratories, biotech
Auxilium a Buy at $20
Yahoo/Zacks.com
Wednesday, May 6, 2009 - 6:10pm
tags:
Auxilium, earnings
Acorda Pops On Good News
Yahoo/Zacks.com
Wednesday, May 6, 2009 - 6:09pm
tags:
Acorda Therapeutics, Biogen Idec, Pfizer, Sanofi
CombinatoRx Cuts Deal for Cancer Drug Discovery with Novartis
Xconomy
Wednesday, May 6, 2009 - 10:13am
tags:
CombinatoRx, cancer, partnerships, Novartis

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels
GLP-1 For Everything
In the Pipeline
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement- Phoenix, AZ
Phoenix, Arizona,
Otsuka
Account Manager-Queens West, NY-Ophthalmics
Rego Park, New York, 11374
Sun Pharmaceutical Industries, Inc.
Account Manager-Queens West, NY-Ophthalmics
East Orange, New Jersey, 07017
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement - San Diego S, CA
San Diego, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Thousand Oaks, CA
Thousand Oaks, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia,
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Portland E, OR
Portland, Oregon,
Otsuka
Psychiatry Account Manager - Greenville West, SC
Greenville, South Carolina, US
Lundbeck
Account Manager-Queens West, NY-Ophthalmics
Passaic, New Jersey, 07055
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information